Compare URBN & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | URBN | CAI |
|---|---|---|
| Founded | 1970 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1846 |
| Industry | Clothing/Shoe/Accessory Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.9B |
| IPO Year | 1995 | N/A |
| Metric | URBN | CAI |
|---|---|---|
| Price | $73.71 | $19.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $86.91 | $30.91 |
| AVG Volume (30 Days) | 1.2M | ★ 1.8M |
| Earning Date | 05-20-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.78 | N/A |
| EPS | ★ 5.06 | N/A |
| Revenue | ★ $6,165,376,000.00 | N/A |
| Revenue This Year | $10.67 | $25.24 |
| Revenue Next Year | $7.01 | $22.32 |
| P/E Ratio | $14.82 | ★ N/A |
| Revenue Growth | ★ 11.07 | N/A |
| 52 Week Low | $50.38 | $16.28 |
| 52 Week High | $84.35 | $42.50 |
| Indicator | URBN | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 62.28 | 50.09 |
| Support Level | $72.35 | $17.17 |
| Resistance Level | $74.12 | $21.47 |
| Average True Range (ATR) | 2.60 | 0.97 |
| MACD | 0.97 | 0.16 |
| Stochastic Oscillator | 72.32 | 45.25 |
Founded in 1970, Philadelphia-based Urban Outfitters is a multibrand apparel and home goods retailer that operates nearly 800 stores and e-commerce in the United States, which accounts for about 87% of sales, and other regions. Its retail nameplates are Urban Outfitters (23% of fiscal 2025 sales), Free People/Movement (26%), and Anthropologie (44%). Retail accounted for 88% of fiscal 2025 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (7% of sales). Urban Outfitters primarily markets to young adults and offers products in categories such as apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.